IP Library Granted Patent US 11,998,371
Granted Patent B2
US 11,998,371 · App. 18/195,176 · Granted Jun 4, 2024

Breast compression and imaging systems and methods

Inventors: Shawn St. Pierre (The Hills, TX); Alan Rego (Woodbury, CT); Richard Gladwin Edwards (Brookfield, CT); Joseph Vartolone (Danbury, CT); Timothy Wells (Manchester, CT)
Assignee: Hologic, Inc.
A61B6/0414A61B6/0435A61B6/0492A61B6/461A61B6/502
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,998,371
App. No.
18/195,176
Granted
Jun 4, 2024
Kind
B2
Abstract

A compression paddle with a plurality of markers is advanced towards a patient's breast which has been positioned on a support platform for an imaging procedure. An initial position of the compression paddle is detected relative to the support platform when a portion of the breast is contacted. An initial marker is identified which is associated with a feature of the breast when the compression paddle is in the initial position. A compression target marker is based at least in part on the initial position and the initial marker.

Claims (21)

1. A method of determining a condition of a breast for an imaging procedure, the method comprising:

compressing the breast between a movable compression paddle and a support platform;

monitoring a position of at least a portion of the compression paddle relative to the support platform;

emitting a signal towards a feature disposed on the compression paddle;

receiving a return signal from the feature in response to the emitted signal; and

determining a flexure of the compression paddle based at least in part on the return signal.

2. The method of claim 1 , further comprising calculating a dose to be delivered to the breast based at least in part on the position and the flexure.

3. The method of claim 1 , further comprising:

determining if at least one of the position and the flexure meets a predetermined criteria; and

terminating the compression operation based on the predetermined criteria determination.

4. The method of claim 1 , wherein the emitted signal comprises at least one of a laser signal, an optical signal, and a time-of-flight signal.

5. The method of claim 1 , wherein the feature comprises a machine-readable feature.

6. The method of claim 1 , wherein the return signal comprises the emitted signal reflected by the feature.

7. The method of claim 1 , wherein the feature is disposed on a substantially vertical portion of the compression paddle.

8. The method of claim 1 , wherein the feature is disposed on a substantially horizontal portion of the compression paddle.

9. The method of claim 3 , wherein the predetermined criteria comprises a rate of flexure of the compression paddle.

10. The method of claim 3 , wherein the predetermined criteria comprises a position between the compression paddle and the support platform.

11. The method of claim 1 , wherein the signal emitted towards the feature is emitted from a sensor disposed on a tube head of a breast imaging system, wherein the compression paddle is disposed between the tube head and the support platform.

12. The method of claim 1 , wherein the signal emitted towards the feature is emitted from a sensor disposed on a compression system of a breast imaging system.

13. The method of claim 2 , wherein calculating the dose to be delivered to the breast is based at least in part on a calculated thickness of the breast.

14. The method of claim 1 , wherein determining the flexure of the compression paddle is further based at least in part on the monitored position of the portion of the compression paddle relative to the support platform.

Assignments (4)
RELEASE OF SECURITY INTEREST RECORDED AT REEL/FRAME 065286/0407 Recorded Apr 24, 2026
From: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
To: HOLOGIC, INC.; GEN-PROBE INCORPORATED; FAXITRON BIOPTICS, LLC; BIOTHERANOSTICS, INC.; GEN-PROBE PRODESSE, INC.
Reel/Frame 075457/0767 →
SECURITY INTEREST Recorded Apr 8, 2026
From: BIOTHERANOSTICS, INC.; GEN-PROBE INCORPORATED; GEN-PROBE PRODESSE, INC.; CYTYC CORPORATION; SUROS SURGICAL SYSTEMS, INC.; GYNESONICS, INC.; BOLDER SURGICAL, LLC; FAXITRON BIOPTICS, LLC; HEALTH BEACONS, INC.; HOLOGIC, INC.
To: ROYAL BANK OF CANADA, AS COLLATERAL AGENT
Reel/Frame 075462/0440 →
SECURITY INTEREST Recorded Oct 19, 2023
From: HOLOGIC, INC.; FAXITRON BIOPTICS, LLC; BIOTHERANOSTICS, INC.; GEN-PROBE INCORPORATED; GEN-PROBE PRODESSE, INC.
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 065286/0407 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 9, 2023
From: ST. PIERRE, SHAWN; REGO, ALAN; EDWARDS, RICHARD GLADWIN; VARTOLONE, JOSEPH; WELLS, TIMOTHY
To: HOLOGIC, INC.
Reel/Frame 063584/0129 →
Continuity (4)
Continuation 17744975 · May 16, 2022
Continuation 16981362
Provisional Application 62676472 · May 25, 2018
Related Publication 20230329652A1 · Oct 19, 2023